MO
47
6
LNC
28
3
MET
58
2
AAP
26
5
WM
53
2
NWSA
69
4
MAS
46
3
FCX
44
4
XEL
48
11
O
26
16
ILMN
31
4
BAC
38
3
PNC
48
6
JWN
72
9
BEN
36
4
DOW
47
4
EOG
28
2
IR
46
3
CHD
34
7
NEE
39
9
MO
47
6
LNC
28
3
MET
58
2
AAP
26
5
WM
53
2
NWSA
69
4
MAS
46
3
FCX
44
4
XEL
48
11
O
26
16
ILMN
31
4
BAC
38
3
PNC
48
6
JWN
72
9
BEN
36
4
DOW
47
4
EOG
28
2
IR
46
3
CHD
34
7
NEE
39
9
Financhill
Back

Genmab AS Stock Predictions

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.
Sell
19

GMAB
Genmab AS

Last Price:
$20.31
Seasonality Move:
3.07%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 36.6% based on the past 12 years of stock performance.
  • Genmab AS has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $20.31. The Score for GMAB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 36.6% based on the past 12 years of stock performance.

Genmab AS Stock Rating

Sell
19
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
32.88
52-Week Low:
19.85

Prediction Charts

Market Cap:
12.9B
Price in USD:
20.31
Volume:
1.8M
Beta:
0.70

Technical Analysis

SMA50:
21.85
SMA100:
24.02
SMA200:
26.17
52-Wk Change:
-33.56%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 20.31 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 21.83 21.70 21.84 21.56
Dec-4 21.71 21.65 21.72 21.55
Dec-5 21.95 21.85 21.97 21.80
Dec-6 21.73 21.81 22.02 21.72
Dec-9 21.98 22.11 22.33 21.96
Dec-10 22.17 21.83 22.19 21.81
Dec-11 21.75 21.55 21.78 21.50
Dec-12 20.98 20.65 21.15 20.65
Dec-13 20.46 20.17 20.48 20.12
Dec-16 19.94 20.02 20.37 19.85
Dec-17 19.95 20.03 20.28 19.90
Dec-18 20.76 20.14 21.03 20.12
Dec-19 20.25 20.09 20.33 19.99
Dec-20 20.22 20.31 20.43 20.13

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.28 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.